P3 Health Partners (NASDAQ:PIII) Sees Large Volume Increase

Shares of P3 Health Partners Inc. (NASDAQ:PIIIGet Free Report) saw strong trading volume on Tuesday . 519,091 shares were traded during mid-day trading, an increase of 14% from the previous session’s volume of 454,236 shares.The stock last traded at $1.65 and had previously closed at $1.68.

Analyst Upgrades and Downgrades

Several analysts have commented on the stock. BTIG Research started coverage on shares of P3 Health Partners in a report on Thursday, August 31st. They issued a “buy” rating and a $5.00 price objective for the company. TD Cowen began coverage on P3 Health Partners in a research note on Friday, June 30th. They issued a “market perform” rating for the company.

Get Our Latest Stock Report on PIII

P3 Health Partners Price Performance

The company has a debt-to-equity ratio of 16.13, a current ratio of 0.69 and a quick ratio of 0.69. The company’s 50 day moving average is $2.11 and its 200-day moving average is $2.27.

P3 Health Partners (NASDAQ:PIIIGet Free Report) last posted its quarterly earnings results on Monday, August 7th. The company reported ($0.09) earnings per share for the quarter, topping the consensus estimate of ($0.24) by $0.15. P3 Health Partners had a negative return on equity of 2,471.27% and a negative net margin of 10.92%. The company had revenue of $329.09 million for the quarter, compared to the consensus estimate of $303.30 million. Equities research analysts expect that P3 Health Partners Inc. will post -0.96 earnings per share for the current fiscal year.

Insider Transactions at P3 Health Partners

In other news, major shareholder Pacific Founders Ugp I. Chicago acquired 90,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The shares were bought at an average cost of $2.65 per share, with a total value of $238,500.00. Following the transaction, the insider now owns 50,025,442 shares of the company’s stock, valued at approximately $132,567,421.30. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders purchased a total of 720,000 shares of company stock valued at $1,427,400 in the last quarter. 17.06% of the stock is owned by insiders.

Hedge Funds Weigh In On P3 Health Partners

A number of hedge funds have recently added to or reduced their stakes in the company. Marietta Investment Partners LLC bought a new stake in shares of P3 Health Partners in the 1st quarter worth $26,000. Squarepoint Ops LLC purchased a new position in P3 Health Partners in the 4th quarter worth about $31,000. Walleye Trading LLC purchased a new stake in shares of P3 Health Partners during the 2nd quarter valued at about $34,000. State Board of Administration of Florida Retirement System bought a new stake in shares of P3 Health Partners in the second quarter worth approximately $34,000. Finally, SlateStone Wealth LLC purchased a new position in shares of P3 Health Partners during the second quarter valued at approximately $39,000. 23.57% of the stock is currently owned by hedge funds and other institutional investors.

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.

Further Reading

Receive News & Ratings for P3 Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for P3 Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.